Felicis portfolio AI companies

Aydin Senkut's firm investing across software, healthcare, and consumer. Filtered to companies in AI.

Hiring from these companies? Find the people who work there.

Change the role to whoever you are hiring, or narrow the list below. 500 free credits on sign-up, no card needed.

Built from a search like: “Felicis-backed AI companies”

Ranked by current headcount across Felicis-backed AI companies. Refreshed monthly.

1
Guardant Health· Palo Alto, California, United States
Guardant Health is a leading precision medicine company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, we're transforming patient care by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant® tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer.Important Note for Job Applicants:Guardant Health is aware of recruiting scams where unauthorized individuals use the company's name in fraudulent emails, job postings, and social media messages. Please note that Guardant Health will never ask for money or credit card information during the job application process, nor does the company communicate with candidates via online chatrooms or personal email accounts such as Gmail or Hotmail.
- Post-IPO debt
- 4.9k employees
- Founded 2012
2
Recursion· Salt Lake City, Utah, United States
Recursion (NASDAQ: RXRX) is a clinical stage TechBio company leading the space by decoding biology to radically improve lives. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously generate one of the world’s largest proprietary biological and chemical datasets. Recursion leverages sophisticated machine-learning and AI algorithms to distill from its dataset a collection of trillions of searchable relationships across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine.Recursion is headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life sciences industry collective. Recursion also has offices in Montréal, New York, London, and the Oxford area.Learn more at www.Recursion.com, or connect on X (formerly Twitter) and LinkedIn.
- Post-IPO equity
- 765 employees
- Founded 2013
3
Ginkgo Bioworks· Boston, Massachusetts, United States
Ginkgo Bioworks builds the tools that make biology easier to engineer for everyone. We offer autonomous laboratories that replace manual laboratory work with robotics in the lab, greatly improving the productivity of scientists. Ginkgo's in-house autonomous lab is also available as a "cloud lab" through our Datapoints and Solutions contract research services.
- Grant
- 487 employees
- Founded 2008
Live search
This list is a starting point
I can run a natural-language search across LinkedIn, GitHub, and the open web. Fire one of these, or edit the box up top to match exactly who you're after.
- Felicis AI companies hiringRun
- Felicis AI foundersRun
500 free credits on sign-up, no card needed.
4
DNAnexus· Mountain View, California, United States
Founded in 2009, DNAnexus is the world's most trusted platform for omics data enablement, transforming the most complex data in healthcare into a governed, AI‐ready, reusable asset. DNAnexus gives pharmaceutical, diagnostic, health system, biobank, and regulatory organizations a single platform to contextualize, orchestrate, and federate multimodal omics data, translating it into a source code for discovery. Today, DNAnexus is where the largest globally connected community of scientists synthesizes biological intelligence at unmatched industrial scale. More than 64,000 researchers across 54 countries and 130+ enterprise customers run production‐grade and regulatory‐grade omics work on DNAnexus, processing 135+ petabytes of genomic and multimodal data. Learn more at dnanexus.com.
- Series H
- 275 employees
- Founded 2009
5
Formation Bio· New York, New York, United States
Formation Bio is an AI-native pharma company differentiated by radically more efficient drug development. The company has built proprietary technology platforms to optimize critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. Formation Bio acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop assets faster, unlock greater value per program and ultimately accelerate access to new treatments for patients.2025 CNBC Disruptor 502025 Fierce 15 Award2024 Endpoints 11 Award
- Series D
- 198 employees
- Founded 2013

6
Genesis Molecular AI· Burlingame, California, United States
Genesis Molecular AI – headquartered in Burlingame, CA, with a fully integrated laboratory in San Diego and offices in New York – is pioneering foundation models for molecular AI to unlock a new era of drug design and development. We are using a proprietary state-of-the-art generative and predictive AI platform called GEMS (Genesis Exploration of Molecular Space), to accelerate and optimize small molecule drug discovery.The GEMS platform integrates AI and physics into industry-leading models to generate and optimize drug molecules, including the breakthrough generative diffusion model Pearl for structure prediction. GEMS accelerates hit ID through lead optimization and candidate selection by generating promising molecules for synthesis and experimental testing, and iterating this process through cycles of AI-enabled discovery and optimization.We have leveraged GEMS to build an internal pipeline with multiple programs against high-value targets, including data-poor and canonically undruggable targets where GEMS is uniquely advantaged. In addition, Genesis has signed AI platform collaborations across a range of therapeutic areas including Gilead (2024), and Incyte (2025).Genesis has raised over $300M in funding from top AI, technology and biotech investors, including Andreessen Horowitz, Rock Springs Capital, T. Rowe Price, Fidelity, Radical Ventures, NVentures (NVIDIA's VC arm), BlackRock, and Menlo Ventures. To learn more about Genesis Molecular AI, or current employment opportunities, please visit our website.
- Corporate
- 158 employees
- Founded 2019
7
Cellino· Cambridge, Massachusetts, United States
Cellino is building an ultra-scalable biomanufacturing technology stack for personalized cell, tissue, and organ replacement therapies. Cellino’s vision is transform medicine to enhance healthspan for billions across generations.
- Grant
- 111 employees
- Founded 2017
8
Arena· San Francisco, California, United States
Created by researchers from UC Berkeley, Arena (formerly LMArena) is a community-powered platform to measure and advance the frontier of AI for real-world use. Tens of millions of builders, researchers, and creative professionals come to Arena to use frontier models and give feedback on their responses, shaping a public leaderboard grounded in real-world use.
- Series B
- 102 employees
- Founded 2025
9
BioAge Labs· Emeryville, California, United States
BioAge is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases by targeting the biology of human aging. The Company's lead product candidate, BGE-102, is a potent, orally available, brain-penetrant small-molecule NLRP3 inhibitor being developed for cardiovascular risk and retinal diseases. A Phase 1 SAD/MAD trial of BGE-102 is underway, with topline data including additional MAD cohorts anticipated in 1H26. The Company is also developing long-acting injectable and oral small molecule APJ agonists for obesity. BioAge’s additional preclinical programs, which leverage insights from the Company’s proprietary discovery platform built on human longevity data, address key pathways involved in metabolic aging.BioAge offers a comprehensive compensation package, comprehensive health and wellness benefits (medical, dental, and vision insurance), childcare and fertility benefits, and a 401(k) retirement savings plan with matched employer contributions. We pride ourselves on giving employees many opportunities for career development, including a generous annual budget for continued learning and dedication to training and skill development.At BioAge, everyone matters, and we embrace diversity and differences while we learn from each other. We are an equal opportunity employer. BioAge prohibits discrimination and harassment of any type and affords equal employment opportunities to employees and applicants without regard to race, color, religion, sex, national origin, disability status, protected veteran status, or any other characteristic protected by law. BioAge conforms to the spirit as well as the letter of all applicable laws and regulations.
- Post-IPO equity
- 100 employees
- Founded 2015
10
LabGenius Therapeutics· Canary Wharf, Surrey Quays, Docklands, Rotherhithe, Bermondsey, England, United Kingdom
LabGenius Therapeutics ("LabGenius") is a drug discovery company pioneering the discovery of next-generation therapeutic antibodies. The company’s discovery platform, EVATM, integrates several cutting-edge technologies drawn from the fields of artificial intelligence, robotic automation and synthetic biology. While EVATM is both modality and format-agnostic, LabGenius' internal pipeline is focussed on the development of selectivity-enhanced antibodies for the treatment of solid tumours. The company's novel approach is delivering a pipeline of antibody therapeutics with best-in-class killing profiles.
- Series unknown
- 70 employees
- Founded 2012

Reveal 13 more·500 free credits, no card

Felicis’s AI portfolio

The list above ranks Felicis-backed AI companies by current headcount, drawn from public LinkedIn and Crunchbase records. 18 matching companies in Refolk’s index give you a quick read on where Felicis has gone deepest in the AI space.

Felicis’s AI bets tend to share a thesis. The engineers, ML researchers, and founders inside these companies are often building the same primitives - and they show up in AI talent pools across the next decade.

Refolk converts this list into a live search. Ask for “Felicis AI companies hiring senior engineers” or “founders of Felicis-backed AI companies” and Refolk returns a fresh ranked shortlist.

How this list is built

Refolk pulled AI companies whose disclosed Crunchbase investor list includes Felicis, ranked them by current employee count, and kept those with at least 5 employees. The list refreshes monthly.

Last refreshed: Thu, 29 Oct 2026 16:16:13 GMT

Search this list

Need a more specific search?

Refolk runs natural-language searches across LinkedIn, GitHub, and the open web. Try one of these:

500 free credits on sign-up, no card needed.

Related lists

See all company lists.

Or zoom out

Common questions

How is this ranking built?

The list draws on the public company graph - headcount and growth signals, funding history, and recency. The criteria chips at the top show exactly which filters produced it, and the methodology section explains the ranking.

How fresh is the data?

The underlying index updates continuously and this ranking is rebuilt monthly. Last refreshed: Thu, 29 Oct 2026 16:16:13 GMT. For a list built against the index as it stands today, sign up and run the search live.

Can I find the people inside these companies?

Yes. Ask in plain English - for example "engineering leaders at these companies who joined in the last year" - and I return the specific people, with context on each.

Try it on the search you came here for

Stop building boolean strings. Just describe the person.

Type one sentence. I plan the search, read GitHub, public LinkedIn and Crunchbase records, and the open web as it is right now, and hand back a ranked list with the reason next to every name.

01Describe them
One plain sentence. Role, city, stack, stage, whatever matters to you.
02I read the web live
GitHub, public LinkedIn and Crunchbase records, the open web. Not a database that went stale last quarter.
03You read the shortlist
Ranked, with the reasoning under every name. Open a profile, ask a follow-up, narrow it down.

No boolean, no filters, no seat to buy. One box.
Read at search time, so a profile updated yesterday counts today.
Every step visible as it runs, every name with its reason.

500 free credits on sign-up. No card, no demo call. See real searches.